BJH - volume 10, issue 4, june 2019
T. van Genechten MD, A. Vanderfaeillie MD, M.A. Azerad MD, D. Kieffer PhD, PharmD, V. Labarque MD, PhD, B. Gulbis MD, PhD, A. Ferster MD, PhD, B. De Wilde MD, PhD
With the increasing prevalence of sickle cell disease patients in Western countries, it is of importance to improve awareness among medical doctors of its complications. To reduce long-term morbidity and mortality, the prompt recognition and treatment of acute complications is important. The existing clinical guideline ‘Follow-up and treatment of patients with sickle cell disease hospitalised for Vaso Occlusive Crisis or infection’, published in 2012 by the Belgian Haematological Society, was revisited to better suit the practical needs of first-line practitioners.
(BELG J HEMATOL 2019;10(4):165–8)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
S. van Aelst , K. Desmet , E. Nackers , D. Kieffer PhD, PharmD
BJH - volume 8, issue Abstract Book BHS, february 2017
H. Claerhout MD, E. Lierman PhD, D. Kieffer PhD, PharmD, N. Boeckx MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
H. Claerhout MD, J. Oosterbosch , C.L. Harteveld , E. Lierman PhD, D. Kieffer PhD, PharmD
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
